Predictive Historical Balance Sheet

POAI Stock

USD 0.78 0.02 2.50%

Trend analysis of Predictive Oncology balance sheet accounts such as Total Stockholder Equity of 5 M, Property Plant And Equipment Net of 4.2 M, Current Deferred Revenue of 323.5 K or Accounts Payable of 1.1 M provides information on Predictive Oncology's total assets, liabilities, and equity, which is the actual value of Predictive Oncology to its prevalent stockholders. By breaking down trends over time using Predictive Oncology balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.

Cash Flow Balance Sheet Income Statement

Credit Downgrade

Yuan Drop

Covid

Financial Statement Analysis is much more than just reviewing and examining Predictive Oncology latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Predictive Oncology is a good buy for the upcoming year.

Predictive Oncology Inventory

299,087

Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Predictive Oncology. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

For more detail on how to invest in Predictive Stock please use our How to Invest in Predictive Oncology guide.

About Predictive Balance Sheet Analysis

Balance Sheet is a snapshot of the financial position of Predictive Oncology at a specified time, usually calculated after every quarter, six months, or one year. Predictive Oncology Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Predictive Oncology and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Predictive currently owns. An asset can also be divided into two categories, current and non-current.

Predictive Oncology Balance Sheet Chart

As of now, Predictive Oncology's Common Stock Total Equity is decreasing as compared to previous years. The Predictive Oncology's current Common Stock Shares Outstanding is estimated to increase to about 4.2 M, while Total Assets are projected to decrease to under 9.5 M.

Total Assets Short Long Term Debt Total Other Current Liab Total Current Liabilities Current Deferred Revenue Other Current Assets

Add Fundamental

Total Assets

Total assets refers to the total amount of Predictive Oncology assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Predictive Oncology books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.

Total Current Liabilities

Total Current Liabilities is an item on Predictive Oncology balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Predictive Oncology are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.

Current Deferred Revenue

Revenue that has been collected but not yet earned, typically from prepaid service contracts or subscriptions. This amount is considered a liability until the service is provided or the subscription period ends.

Other Current Assets

Assets expected to be converted into cash, sold, or consumed either in one year or in the operating cycle, which are not included under standard current asset categories.

Most accounts from Predictive Oncology's balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into Predictive Oncology current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Predictive Oncology. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

For more detail on how to invest in Predictive Stock please use our How to Invest in Predictive Oncology guide.As of now, Predictive Oncology's Common Stock Total Equity is decreasing as compared to previous years. The Predictive Oncology's current Common Stock Shares Outstanding is estimated to increase to about 4.2 M, while Total Assets are projected to decrease to under 9.5 M.

	2021	2022	2023	2024 (projected)
Short and Long Term Debt Total	879.3K	180.3K	2.9M	1.9M
Total Assets	43.8M	25.7M	14.4M	9.5M

Short Long Term Debt Total Total Assets

Predictive Oncology balance sheet Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Cash And Short Term Investments	Common Stock Total Equity	Common Stock Shares Outstanding	Non Current Liabilities Total	Other Current Assets	Other Stockholder Equity	Total Liab	Property Plant And Equipment Gross	Total Current Assets	Short Term Debt	Intangible Assets	Common Stock	Net Receivables	Inventory
Total Assets		0.18	0.21	0.32	0.97	0.62	0.54	-0.76	-0.69	0.32	0.86	0.73	0.86	-0.25	0.59	0.06	0.61	0.75	0.31	0.52	0.87	0.14	0.73	0.0	0.25	0.56
Short Long Term Debt Total	0.18		0.41	0.78	-0.02	0.58	-0.09	0.44	-0.27	0.55	-0.27	0.71	-0.27	-0.29	-0.05	0.32	0.0	0.23	0.81	0.28	-0.26	0.93	0.63	-0.39	0.15	0.06
Other Current Liab	0.21	0.41		0.81	0.02	0.43	0.26	0.1	-0.33	0.7	0.0	0.4	0.0	0.12	0.11	0.09	0.0	0.28	0.79	0.27	0.01	0.42	0.37	0.14	-0.03	0.38
Total Current Liabilities	0.32	0.78	0.81		0.08	0.54	0.1	0.28	-0.3	0.87	-0.11	0.75	-0.11	-0.07	0.03	0.16	-0.07	0.27	0.98	0.29	-0.1	0.77	0.67	-0.08	0.02	0.15
Total Stockholder Equity	0.97	-0.02	0.02	0.08		0.49	0.52	-0.87	-0.63	0.12	0.93	0.57	0.93	-0.24	0.59	-0.02	0.65	0.71	0.07	0.45	0.93	-0.05	0.6	0.03	0.26	0.54
Property Plant And Equipment Net	0.62	0.58	0.43	0.54	0.49		0.51	-0.28	-0.85	0.37	0.4	0.61	0.4	-0.2	0.71	0.69	0.46	0.84	0.62	0.87	0.41	0.34	0.58	-0.17	0.18	0.57
Current Deferred Revenue	0.54	-0.09	0.26	0.1	0.52	0.51		-0.65	-0.81	0.1	0.67	0.1	0.67	0.01	0.85	0.4	0.52	0.8	0.15	0.75	0.67	-0.25	-0.01	0.17	0.19	0.66
Net Debt	-0.76	0.44	0.1	0.28	-0.87	-0.28	-0.65		0.55	0.17	-0.98	-0.11	-0.98	0.12	-0.66	0.02	-0.63	-0.62	0.28	-0.41	-0.98	0.48	-0.16	-0.16	-0.13	-0.58
Retained Earnings	-0.69	-0.27	-0.33	-0.3	-0.63	-0.85	-0.81	0.55		-0.23	-0.63	-0.43	-0.63	0.25	-0.91	-0.61	-0.71	-0.99	-0.37	-0.94	-0.64	-0.05	-0.33	0.16	-0.38	-0.81
Accounts Payable	0.32	0.55	0.7	0.87	0.12	0.37	0.1	0.17	-0.23		-0.04	0.68	-0.04	-0.06	0.08	0.15	-0.1	0.22	0.85	0.26	-0.04	0.52	0.5	-0.08	-0.14	0.17
Cash	0.86	-0.27	0.0	-0.11	0.93	0.4	0.67	-0.98	-0.63	-0.04		0.28	1.0	-0.16	0.68	0.01	0.66	0.69	-0.1	0.47	1.0	-0.32	0.33	0.13	0.16	0.63
Non Current Assets Total	0.73	0.71	0.4	0.75	0.57	0.61	0.1	-0.11	-0.43	0.68	0.28		0.28	-0.23	0.18	0.09	0.21	0.47	0.73	0.34	0.28	0.7	0.93	-0.15	0.22	0.18
Cash And Short Term Investments	0.86	-0.27	0.0	-0.11	0.93	0.4	0.67	-0.98	-0.63	-0.04	1.0	0.28		-0.16	0.68	0.01	0.66	0.69	-0.1	0.47	1.0	-0.32	0.33	0.13	0.15	0.63
Common Stock Total Equity	-0.25	-0.29	0.12	-0.07	-0.24	-0.2	0.01	0.12	0.25	-0.06	-0.16	-0.23	-0.16		-0.15	-0.04	-0.42	-0.27	-0.07	-0.17	-0.18	-0.26	-0.2	0.94	-0.25	-0.4
Common Stock Shares Outstanding	0.59	-0.05	0.11	0.03	0.59	0.71	0.85	-0.66	-0.91	0.08	0.68	0.18	0.68	-0.15		0.66	0.62	0.92	0.11	0.93	0.69	-0.31	0.07	-0.06	0.19	0.72
Non Current Liabilities Total	0.06	0.32	0.09	0.16	-0.02	0.69	0.4	0.02	-0.61	0.15	0.01	0.09	0.01	-0.04	0.66		0.13	0.56	0.3	0.81	0.01	-0.02	-0.04	-0.21	-0.06	0.35
Other Current Assets	0.61	0.0	0.0	-0.07	0.65	0.46	0.52	-0.63	-0.71	-0.1	0.66	0.21	0.66	-0.42	0.62	0.13		0.72	-0.04	0.53	0.69	-0.11	0.21	-0.25	0.68	0.78
Other Stockholder Equity	0.75	0.23	0.28	0.27	0.71	0.84	0.8	-0.62	-0.99	0.22	0.69	0.47	0.69	-0.27	0.92	0.56	0.72		0.33	0.92	0.71	0.02	0.38	-0.15	0.37	0.79
Total Liab	0.31	0.81	0.79	0.98	0.07	0.62	0.15	0.28	-0.37	0.85	-0.1	0.73	-0.1	-0.07	0.11	0.3	-0.04	0.33		0.39	-0.09	0.74	0.64	-0.1	0.01	0.21
Property Plant And Equipment Gross	0.52	0.28	0.27	0.29	0.45	0.87	0.75	-0.41	-0.94	0.26	0.47	0.34	0.47	-0.17	0.93	0.81	0.53	0.92	0.39		0.48	-0.01	0.21	-0.16	0.18	0.67
Total Current Assets	0.87	-0.26	0.01	-0.1	0.93	0.41	0.67	-0.98	-0.64	-0.04	1.0	0.28	1.0	-0.18	0.69	0.01	0.69	0.71	-0.09	0.48		-0.31	0.33	0.11	0.2	0.65
Short Term Debt	0.14	0.93	0.42	0.77	-0.05	0.34	-0.25	0.48	-0.05	0.52	-0.32	0.7	-0.32	-0.26	-0.31	-0.02	-0.11	0.02	0.74	-0.01	-0.31		0.67	-0.32	0.14	-0.11
Intangible Assets	0.73	0.63	0.37	0.67	0.6	0.58	-0.01	-0.16	-0.33	0.5	0.33	0.93	0.33	-0.2	0.07	-0.04	0.21	0.38	0.64	0.21	0.33	0.67		-0.09	0.21	0.14
Common Stock	0.0	-0.39	0.14	-0.08	0.03	-0.17	0.17	-0.16	0.16	-0.08	0.13	-0.15	0.13	0.94	-0.06	-0.21	-0.25	-0.15	-0.1	-0.16	0.11	-0.32	-0.09		-0.2	-0.27
Net Receivables	0.25	0.15	-0.03	0.02	0.26	0.18	0.19	-0.13	-0.38	-0.14	0.16	0.22	0.15	-0.25	0.19	-0.06	0.68	0.37	0.01	0.18	0.2	0.14	0.21	-0.2		0.33
Inventory	0.56	0.06	0.38	0.15	0.54	0.57	0.66	-0.58	-0.81	0.17	0.63	0.18	0.63	-0.4	0.72	0.35	0.78	0.79	0.21	0.67	0.65	-0.11	0.14	-0.27	0.33

Click cells to compare fundamentals

Predictive Oncology Account Relationship Matchups

Predictive Oncology balance sheet Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	22.4M	13.1M	43.8M	25.7M	14.4M	9.5M
Short Long Term Debt Total	5.5M	5.9M	879.3K	180.3K	2.9M	1.9M
Other Current Liab	2.4M	2.9M	1.4M	2.1M	1.6M	1.6M
Total Current Liabilities	10.9M	9.3M	3.2M	3.9M	4.0M	4.0M
Total Stockholder Equity	11.2M	2.6M	40.3M	21.8M	8.3M	5.0M
Property Plant And Equipment Net	2.2M	5.2M	3.3M	2.0M	4.0M	4.2M
Current Deferred Revenue	40.4K	53.0K	187.0K	602.1K	308.1K	323.5K
Net Debt	5.4M	5.2M	(27.3M)	(21.9M)	(5.9M)	(5.6M)
Retained Earnings	(82.5M)	(108.4M)	(128.0M)	(153.8M)	(167.8M)	(159.4M)
Accounts Payable	3.2M	1.4M	1.0M	943.5K	1.3M	1.1M
Cash	150.8K	678.3K	28.2M	22.1M	8.7M	4.7M
Non Current Assets Total	21.6M	11.5M	14.3M	2.4M	4.3M	4.1M
Cash And Short Term Investments	150.8K	678.3K	28.2M	22.1M	8.7M	4.7M
Common Stock Total Equity	69.4K	140.9K	40.6K	198.0K	178.2K	275.4K
Common Stock Shares Outstanding	143.5K	597.5K	2.7M	3.6M	4.0M	4.2M
Liabilities And Stockholders Equity	22.4M	13.1M	43.8M	25.7M	14.4M	9.5M
Non Current Liabilities Total	270.3K	1.1M	265.1K	86.1K	2.2M	2.3M
Other Current Assets	160.2K	289.5K	513.8K	526.8K	521.7K	263.4K
Other Stockholder Equity	93.7M	110.8M	167.6M	174.8M	176.0M	184.8M
Total Liab	11.1M	10.4M	3.5M	4.0M	6.1M	4.6M
Property Plant And Equipment Gross	2.2M	3.8M	3.3M	4.9M	7.6M	7.9M
Total Current Assets	798.3K	1.5M	29.5M	23.4M	10.1M	5.5M
Short Term Debt	5.3M	5.0M	639.7K	188.5K	667.8K	634.4K
Intangible Assets	3.6M	3.4M	4.0M	253.9K	252.5K	239.8K
Common Stock	40.6K	198.0K	656.1K	787.6K	40.6K	38.6K
Net Receivables	297.1K	256.9K	354.2K	331.2K	333.7K	270.7K
Inventory	190.2K	289.5K	387.7K	430.5K	494.4K	299.1K
Non Currrent Assets Other	(21.6M)	116.3K	167.1K	75.6K	124.1K	130.3K
Accumulated Other Comprehensive Income	(273.8K)	(358.8K)	(771.6K)	(792.0)	(712.8)	(748.44)
Capital Surpluse	57.4M	63.0M	93.7M	110.8M	127.5M	70.3M
Property Plant Equipment	2.2M	5.2M	3.3M	2.0M	2.4M	1.7M
Net Tangible Assets	(8.1M)	(3.6M)	29.4M	21.5M	24.7M	26.0M
Net Invested Capital	16.0M	7.1M	40.3M	21.8M	8.4M	15.4M
Net Working Capital	(10.1M)	(7.8M)	26.2M	19.5M	6.1M	5.2M
Capital Stock	76.4K	198.8K	656.9K	788.4K	41.4K	39.3K

Currently Active Assets on Macroaxis

V	Visa Class A
GOOG	Alphabet Inc Class C
GOOG	Alphabet Inc Class C
MSFT	Microsoft
GM	General Motors

When determining whether Predictive Oncology offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Predictive Oncology's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Predictive Oncology Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Predictive Oncology Stock:

How To Invest In Predictive

Details

Is Predictive Stock a good investment?

Details

What is Predictive Oncology's Net Worth?

Details

Largest Health Care Equipment & Supplies Companies

View

Largest Health Care Equipment & Services Companies

View

For more detail on how to invest in Predictive Stock please use our How to Invest in Predictive Oncology guide.

You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.

Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Predictive Oncology. If investors know Predictive will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Predictive Oncology listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(2.96)

Revenue Per Share

0.416

Quarterly Revenue Growth

(0.43)

Return On Assets

(0.56)

Return On Equity

(1.49)

The market value of Predictive Oncology is measured differently than its book value, which is the value of Predictive that is recorded on the company's balance sheet. Investors also form their own opinion of Predictive Oncology's value that differs from its market value or its book value, called intrinsic value, which is Predictive Oncology's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Predictive Oncology's market value can be influenced by many factors that don't directly affect Predictive Oncology's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Predictive Oncology's value and its price as these two are different measures arrived at by different means. Investors typically determine if Predictive Oncology is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Predictive Oncology's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Predictive Historical Balance Sheet

Predictive Oncology Inventory

299,087

About Predictive Balance Sheet Analysis

Predictive Oncology Balance Sheet Chart

Total Assets

Total Current Liabilities

Current Deferred Revenue

Other Current Assets

Predictive Oncology balance sheet Correlations

Predictive Oncology Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Predictive Oncology balance sheet Accounts

Currently Active Assets on Macroaxis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Cash And Short Term Investments	+ 1.0	Cash
Total Current Assets	+ 1.0	Cash
Total Current Assets	+ 1.0	Cash And Short Term Investments
Total Liab	+ 0.98	Total Current Liabilities
Total Stockholder Equity	+ 0.97	Total Assets
Common Stock	+ 0.94	Common Stock Total Equity

Other Stockholder Equity	- 0.99	Retained Earnings
Total Current Assets	- 0.98	Net Debt
Cash And Short Term Investments	- 0.98	Net Debt
Cash	- 0.98	Net Debt
Property Plant And Equipment Gross	- 0.94	Retained Earnings
Common Stock Shares Outstanding	- 0.91	Retained Earnings